Alpine Partners VI »

BioCryst Pharmaceuticals shares owned by Alpine Partners VI

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $124k 20k 6.18

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Blackrock Muni Intermediate Drtn Fnd (MUI)
Burlington Stores Note 2.250% 4/1
Redfin Corp Note 0.500% 4/0
Blackrock Capital Allocation Trust (BCAT)
Rivian Automotive Note 4.625% 3/1
Stericycle (SRCL)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Pagaya Technologies Cl A New (PGY)
Jazz Investments I Note 2.000% 6/1
ON Semiconductor (ON)

View all positions for Alpine Partners VI

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Kynam Capital Management
State Street Corporation
Deerfield Management Company
Alkeon Capital Management
Geode Capital Management
Nuveen Asset Management
RP Management
Rock Springs Capital Management
Fisher Investments
Jennifer Ranahan
Caligan Partners
Goldman Sachs Group

View all funds holding BioCryst Pharmaceuticals